Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
Open Access
- 25 January 2010
- journal article
- review article
- Published by Wiley in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
- Vol. 77 (1), 50-58
- https://doi.org/10.1002/msj.20163
Abstract
Alzheimer's disease is a chronic, age‐related neurodegenerative disorder. Neurofibrillary tangles are among the pathological hallmarks of Alzheimer's disease. Neurofibrillary tangles consist of abnormal protein fibers known as paired helical filaments. The accumulation of paired helical filaments is one of the most characteristic cellular changes in Alzheimer's disease. Tau protein, a microtubule‐associated protein, is the major component of paired helical filaments. Tau in paired helical filaments is hyperphosphorylated, truncated, and aggregated. What triggers the formation of paired helical filaments is not known, but neuroinflammation could play a role. Neuroinflammation is an active process detectable in the earliest stages of Alzheimer's disease. The neuronal toxicity associated with inflammation makes it a potential risk factor in the pathogenesis of Alzheimer's disease. Determining the sequence of events that lead to this devastating disease has become one of the most important goals for the prevention and treatment of Alzheimer's disease. In this review, we focus on the pathological properties of tau thought to play a role in neurofibrillary tangle formation and summarize how central nervous system inflammation might be a critical contributor to the pathology of Alzheimer's disease. A better understanding of the mechanisms that cause neurofibrillary tangle formation is of clinical importance for developing therapeutic strategies to prevent and treat Alzheimer's disease. One of the major challenges facing us is singling out neuroinflammation as a therapeutic target for the prevention of Alzheimer's disease neurodegeneration. The challenge is developing therapeutic strategies that prevent neurotoxicity linked to inflammation without compromising its neuroprotective role. Mt Sinai J Med 77:50&–58, 2010. © 2010 Mount Sinai School of MedicineKeywords
This publication has 60 references indexed in Scilit:
- Tau fragmentation, aggregation and clearance: the dual role of lysosomal processingHuman Molecular Genetics, 2009
- Proteasome–caspase–cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cellsJournal of Neurochemistry, 2009
- Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease modelsMolecular and Cellular Neuroscience, 2008
- Active c‐jun N‐terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK‐3β is required for tau aggregationEuropean Journal of Neuroscience, 2008
- Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesisProceedings of the National Academy of Sciences of the United States of America, 2008
- Akt and CHIP coregulate tau degradation through coordinated interactionsProceedings of the National Academy of Sciences of the United States of America, 2008
- Interactions between APP secretases and inflammatory mediatorsJournal of Neuroinflammation, 2008
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteinsJCI Insight, 2007
- CHIP-ping away at tauJCI Insight, 2007
- Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degenerationEuropean Journal of Neuroscience, 2007